Branded Cannabis: Revolutionizing the Industry

Part of the Cannabis Intelligence Briefing series.

Branded Cannabis: Revolutionizing the Industry, covers the rapid evolution of cannabis-derived consumables in the U.S. from its illicit roots to legal retail legitimacy. Both cannabis-based products containing THC and hemp-derived CBD have earned high demand status in both adult-use dispensaries and mass markets. The United States presents a current growth model expected to be replicated in Canada and other nations around the world over the next five years.

A few key highlights from the report:

  • Cannabis legalization is on the brink of entering the sophisticated industry of consumer packaged goods. For now, Federal prohibition insulates cannabis start-ups from the competition of industry giants that would otherwise dominate the market. Few products, if any, have faced this extraordinary market potential.
  • Increased access to cannabis has resulted in both a significant increase in sales and an expansion and diversification of the consumer base. Access to this new base has created vast opportunities for segmentation targeting and branding.
  • The market opportunity for legal cannabis in the United States continues to be tremendous. U.S. legal cannabis sales exceeded $12.4 billion in 2019 and are expected to reach $31.4 billion in 2024, rising at a CAGR of nearly 23% from $9.1 billion in 2018.
  • The U.S. cannabis market is much more than just the licensed dispensary channel in legal cannabis states; it also includes the market for non-psychoactive cannabinoids, such as CBD derived from hemp—legally defined as Cannabis sativa bearing less than 0.3% THC.
    • Total sales of CBD products in the U.S. reached nearly $2.6 billion in 2019 and are forecast to break $18 billion in 2024, growing at a CAGR of almost 52% from just $1.5 billion in 2018.
  • The passage of the 2018 “Farm Bill” reinvigorated the market for CBD products by legalizing the cultivation of low-THC hemp in the U.S. Non-edible CBD products are proliferating. Manufacturers, even the giants of the CPG industry, now eagerly await FDA approval of CBD as a food additive—a move expected to throw the market wide open.

 

*FULFILLMENT TAKES UP TO 1 BUSINESS DAY

$0

Share this page

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

Related Market Reports

Get the latest industry data to drive your decisions

The Arcview Group

The Arcview Group is a vertically integrated company servicing the cannabis and hemp industry, built with social justice and responsibility at its core. Arcview has been a trusted global leader for over ten years and nexus for investors, companies, entrepreneurs, and community, providing a broad spectrum of programs and services.

© 2021 The Arcview Group. All rights reserved.

Subscribe to Arcview Newsletter

Get exclusive announcements, invitations to our upcoming events, special offers, and more!

Arcview Capital

Please be advised you are leaving the Arcview Group domain.